Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pfister

Showing results (161-170 of 288) with videos related to

Pageof 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinomaR J Wong, D T Lin, H Schöder, et al.
The American Journal of Pathology|August 7, 2002
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomasBhuvanesh Singh, Archontoula Stoffel, Swarna Gogineni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional studyD F Bajorin, M F Sarosdy, D G Pfister, et al.
Head & Neck|May 1, 1997
Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongueL B Harrison, M J Zelefsky, D G Pfister, et al.
Cancers of the Head & Neck|May 17, 2019
Employment and return to work following chemoradiation in patient with HPV-related oropharyngeal cancerShrujal S Baxi, Talya Salz, Han Xiao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2008
Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancerSeng Chuan Ong, Heiko Schöder, Nancy Y Lee, et al.
Journal of the National Cancer Institute|March 6, 1991
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologiesR J Motzer, E Rodriguez, V E Reuter, et al.
Oral Oncology|May 8, 2025
Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancerJennifer R Cracchiolo, Michael T Starc, Richard J Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibitionRowan T Chlebowski, Nananda Col, Eric P Winer, et al.
Cancer|March 10, 2001
The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinomaE J Sherman, D G Pfister, H S Ruchlin, et al.
Pageof 29

Showing results (161-170 of 288) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinomaR J Wong, D T Lin, H Schöder, et al.
The American Journal of Pathology|August 7, 2002
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomasBhuvanesh Singh, Archontoula Stoffel, Swarna Gogineni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional studyD F Bajorin, M F Sarosdy, D G Pfister, et al.
Head & Neck|May 1, 1997
Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongueL B Harrison, M J Zelefsky, D G Pfister, et al.
Cancers of the Head & Neck|May 17, 2019
Employment and return to work following chemoradiation in patient with HPV-related oropharyngeal cancerShrujal S Baxi, Talya Salz, Han Xiao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2008
Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancerSeng Chuan Ong, Heiko Schöder, Nancy Y Lee, et al.
Journal of the National Cancer Institute|March 6, 1991
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologiesR J Motzer, E Rodriguez, V E Reuter, et al.
Oral Oncology|May 8, 2025
Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancerJennifer R Cracchiolo, Michael T Starc, Richard J Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibitionRowan T Chlebowski, Nananda Col, Eric P Winer, et al.
Cancer|March 10, 2001
The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinomaE J Sherman, D G Pfister, H S Ruchlin, et al.
Pageof 29